Clinical Trial

A Study of Cizutamig in Patients With Immunoglobulin A Nephropathy

Name: A Study of Cizutamig in Patients With Immunoglobulin A Nephropathy — clinical trial record (NCT07135219)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation Early Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated August 22, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Summary

The purpose of this study is to assess the safety, tolerability, PK, PD, immunogenicity, and preliminary clinical activity of cizutamig in patients with IgAN.

Trial Details

NCT Number	NCT07135219
Lead Sponsor	Peking University First Hospital
Conditions	Immunoglobulin A Nephropathy (IgAN)
Enrollment	15 participants
Start Date	2025-07-16
Primary Completion	2025-12 (estimated)
Study Completion	2027-01 (estimated)
Updated on ClinicalTrials.gov	2025-08-22